📰 Roberte Hoffman News
Roberte Hoffman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roberte Hoffman. Real-time updates on events, politics, business and more.
April 25, 2024
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology Annual Meeting TAMPA, FL&SAN...
April 3, 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger ...
April 1, 2024
Antibe Therapeutics Inc. today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration that otenaproxesul has been placed on clinical...
March 27, 2024
SAN DIEGO, March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today
February 15, 2024
SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today
February 14, 2024
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
December 1, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
October 31, 2023
VAL-083 did not improve efficacy compared with standard-of-care approaches in patients with glioblastoma.
September 18, 2023
SAN DIEGO, Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results...
September 9, 2023
TORONTO — Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation…